SCHEMBL6713083

SCHEMBL6713083

O=C(Nc1ccc(Br)cc1-c1noc(=O)[nH]1)c1cc2ccc(OCc3ccccc3)cc2[nH]1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 1/20 0.45
PDGFRB P09619 1/20 0.42
PDGFRA P16234 1/20 0.42
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
HPGD P15428 1/20 0.42
SRD5A2 P31213 1/20 0.42
HSD17B10 Q99714 1/20 0.42
HDAC1 Q13547 3/20 0.41
HDAC2 Q92769 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38
SIRT2 Q8IXJ6 1/20 0.38
SIRT1 Q96EB6 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6711692 0.94 KDM4E (0.51) FLT3PDGFRBPDGFRAKDM4EALDH1A1
SCHEMBL6713520 0.90 FLT3 (0.45) FLT3PDGFRBPDGFRAKDM4EALDH1A1
SCHEMBL6710053 0.88 FLT3 (0.43) FLT3PDGFRBPDGFRAKDM4EALDH1A1
SCHEMBL6712124 0.86 KDM4E (0.47) FLT3PDGFRBPDGFRAKDM4EALDH1A1
SCHEMBL6709194 0.85 FLT3 (0.45) FLT3PDGFRBPDGFRAKDM4EALDH1A1
SCHEMBL7126152 0.84 PDGFRB (0.42) FLT3PDGFRBPDGFRAKDM4EALDH1A1
SCHEMBL6713696 0.84 SMPD1 (0.50) ALDH1A1HDAC1MEN1KMT2ANPC1
SCHEMBL6710169 0.84 KDM4E (0.51) FLT3PDGFRBPDGFRAKDM4EALDH1A1
SCHEMBL6920226 0.84 LRRK2 (0.40) KDM4EALDH1A1CYP1A2CYP2C9HPGD
SCHEMBL6707759 0.83 NPC1 (0.49) KDM4EALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed
WO-2004018461-A2 ANTIBACTERIAL BENZOIC ACID DERIVATIVES PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 FLT3 1614/4885PDGFRB 236/4885PDGFRA 65/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.